Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice.
暂无分享,去创建一个
T. Jenssen | R. Myklebust | R Myklebust | S N Zykova | T G Jenssen | M Berdal | R Olsen | R Seljelid | R. Seljelid | R. Olsen | S. Zykova | M. Berdal | R. Olsen | Margrete Berdal
[1] C. Nathan,et al. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.
[2] L. Mazzanti,et al. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets , 1999, Diabetologia.
[3] H. Hill,et al. Functional and metabolic abnormalities of diabetic monocytes. , 1982, Advances in experimental medicine and biology.
[4] P. Efron,et al. Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. , 1997, Surgery.
[5] J. Bennedsen,et al. Monocyte functions in diabetes mellitus. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.
[6] M. Kasuga,et al. Accumulation of Pyrraline-modified Albumin in Phagocytes due to Reduced Degradation by Lysosomal Enzymes* , 1997, The Journal of Biological Chemistry.
[7] A. Desfaits,et al. Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment , 1998, Diabetes Care.
[8] P. Damsbo,et al. Circulating monocytes are activated in newly diagnosed type 1 diabetes mellitus patients , 1994, Clinical and experimental immunology.
[9] D. Greenhalgh,et al. Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. , 1997, The American journal of pathology.
[10] H. Drexhage,et al. Defective maturation and function of antigen-presenting cells in type 1 diabetes , 1995, The Lancet.
[11] R. Ross,et al. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.
[12] M. Goppelt‐Struebe,et al. Fluorometric determination of the DNA content of cells cultured in tissue culture plates. , 1992, Journal of immunological methods.
[13] A. Rabinovitch,et al. Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund's adjuvant: a possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes. , 1992, Clinical immunology and immunopathology.
[14] J. Drapier,et al. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. , 1988, Journal of immunology.
[15] L. Tartaglia,et al. Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.
[16] M. Brownlee,et al. Glycation Products and the Pathogenesis of Diabetic Complications , 1992, Diabetes Care.
[17] Ptak,et al. Macrophage function in alloxan diabetic mice: expression of adhesion molecules, generation of monokines and oxygen and NO radicals , 1998, Clinical and experimental immunology.
[18] D. Greenhalgh,et al. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.
[19] N. Shinomiya,et al. Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes , 1992, Clinical and experimental immunology.
[20] J. Friedman,et al. Abnormal splicing of the leptin receptor in diabetic mice , 1996, Nature.
[21] Gary R. Grotendorst,et al. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. , 1985, The Journal of clinical investigation.
[22] K. Tracey,et al. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.
[23] R. Arnold,et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. , 1997, Journal of periodontology.
[24] C. Secombes. Isolation of salmonid macrophages and analysis of their killing activity , 1990 .
[25] M. Bitar. Insulin-Like Growth Factor-1 Reverses Diabetes-Induced Wound Healing Impairment in Rats , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[26] B. Kulseng,et al. TNF Production from Peripheral Blood Mononuclear Cells in Diabetic Patients after Stimulation with Alginate and Lipopolysaccharide , 1996, Scandinavian journal of immunology.
[27] M. Lane,et al. Leptin regulates proinflammatory immune responses. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] Y. Ohno,et al. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. , 1993, The Journal of clinical endocrinology and metabolism.
[29] S. Marshall,et al. Dysregulation of PMN antigen expression in Type 2 diabetes may reflect a generalized defect of exocytosis: influence of hypertension and microalbuminuria , 1999, Journal of leukocyte biology.
[30] G. Grunberger,et al. Receptor-mediated endocytosis of insulin: inhibition of [125I]iodoinsulin internalization in insulin resistant diabetic states of man. , 1989, Acta endocrinologica.
[31] K Takahashi,et al. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[32] T. Luger,et al. Cytokine production in patients with newly diagnosed insulin‐dependent (type I) diabetes mellitus , 1988, European journal of clinical investigation.
[33] P. Fishman,et al. Phagocytotic Activity of Monocytes from Diabetic Patients , 1983, Diabetes Care.
[34] D. Sutherland,et al. Insulin down-regulates the inducible nitric oxide synthase pathway: nitric oxide as cause and effect of diabetes? , 1997, Journal of Immunology.
[35] M. Knip,et al. Defective HLA class II expression in monocytes of type 1 diabetic patients , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[36] F. Chang,et al. Respiratory burst activity of monocytes from patients with non-insulin-dependent diabetes mellitus. , 1995, Diabetes research and clinical practice.
[37] M. Ferguson,et al. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1 , 1999, Diabetologia.
[38] M. Caldwell,et al. Regulation of macrophage functions by L-arginine , 1989, The Journal of experimental medicine.
[39] C. Cutler,et al. Diabetes-induced impairment of macrophage cytokine release in a rat model: potential role of serum lipids. , 1998, Life sciences.
[40] M. Mcdaniel,et al. Hyperglycemic Levels of Glucose Inhibit Interleukin 1 Release from RAW 264.7 Murine Macrophages by Activation of Protein Kinase C* , 1998, The Journal of Biological Chemistry.
[41] G. A. Holloway,et al. Randomized Prospective Double-Blind Trial in Healing Chronic Diabetic Foot Ulcers: CT-102 activated platelet supernatant, topical versus placebo , 1992, Diabetes Care.
[42] R. Arnold,et al. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. , 1997, Journal of clinical periodontology.